Sugimoto T - Search Results

1

Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model.

Fujimoto T, Andoh T, Sudo T, Fujita I, Moritake H, Sugimoto T, Sakuma T, Akisue T, Kawabata S, Kirihata M, Suzuki M, Sakurai Y, Ono K, Fukumori Y, Kurosaka M, Ichikawa H. Fujimoto T, et al. Among authors: sugimoto t. Appl Radiat Isot. 2013 Mar;73:96-100. doi: 10.1016/j.apradiso.2012.12.001. Epub 2012 Dec 11. Appl Radiat Isot. 2013. PMID: 23306161

2

Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.

Andoh T, Fujimoto T, Sudo T, Suzuki M, Sakurai Y, Sakuma T, Moritake H, Sugimoto T, Takeuchi T, Sonobe H, Epstein AL, Fukumori Y, Ono K, Ichikawa H. Andoh T, et al. Among authors: sugimoto t. Appl Radiat Isot. 2014 Jun;88:59-63. doi: 10.1016/j.apradiso.2013.12.007. Epub 2013 Dec 17. Appl Radiat Isot. 2014. PMID: 24389062

3

Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST).

Fujimoto T, Andoh T, Sudo T, Fujita I, Fukase N, Takeuchi T, Sonobe H, Inoue M, Hirose T, Sakuma T, Moritake H, Sugimoto T, Kawamoto T, Fukumori Y, Yamamoto S, Atagi S, Sakurai Y, Kurosaka M, Ono K, Ichikawa H, Suzuki M. Fujimoto T, et al. Among authors: sugimoto t. Appl Radiat Isot. 2015 Dec;106:220-5. doi: 10.1016/j.apradiso.2015.07.059. Epub 2015 Aug 3. Appl Radiat Isot. 2015. PMID: 26278348

4

Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS.

Andoh T, Fujimoto T, Suzuki M, Sudo T, Sakurai Y, Tanaka H, Fujita I, Fukase N, Moritake H, Sugimoto T, Sakuma T, Sasai H, Kawamoto T, Kirihata M, Fukumori Y, Akisue T, Ono K, Ichikawa H. Andoh T, et al. Among authors: sugimoto t. Appl Radiat Isot. 2015 Dec;106:195-201. doi: 10.1016/j.apradiso.2015.07.060. Epub 2015 Aug 21. Appl Radiat Isot. 2015. PMID: 26337135

5

Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.

Moritake H, Sugimoto T, Asada Y, Yoshida MA, Maehara Y, Epstein AL, Kuroda H. Moritake H, et al. Among authors: sugimoto t. Cancer Genet Cytogenet. 2002 May;135(1):48-56. doi: 10.1016/s0165-4608(01)00641-0. Cancer Genet Cytogenet. 2002. PMID: 12072203

6

Newly established Askin tumor cell line and overexpression of focal adhesion kinase in Ewing sarcoma family of tumors cell lines.

Moritake H, Sugimoto T, Kuroda H, Hidaka F, Takahashi Y, Tsuneyoshi M, Yoshida MA, Cui Q, Akiyoshi K, Izumi T, Nunoi H. Moritake H, et al. Among authors: sugimoto t. Cancer Genet Cytogenet. 2003 Oct 15;146(2):102-9. doi: 10.1016/s0165-4608(03)00129-8. Cancer Genet Cytogenet. 2003. PMID: 14553943

7

Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.

Kuroda H, Moritake H, Sawada K, Kuwahara Y, Imoto I, Inazawa J, Sugimoto T. Kuroda H, et al. Among authors: sugimoto t. Cancer Genet Cytogenet. 2005 Apr 15;158(2):172-9. doi: 10.1016/j.cancergencyto.2004.08.032. Cancer Genet Cytogenet. 2005. PMID: 15796965

8

Irinotecan for children with relapsed solid tumors.

Shitara T, Shimada A, Hanada R, Matsunaga T, Kawa K, Mugishima H, Sugimoto T, Mimaya J, Manabe A, Tsurusawa M, Tsuchida Y. Shitara T, et al. Among authors: sugimoto t. Pediatr Hematol Oncol. 2006 Mar;23(2):103-10. doi: 10.1080/08880010500457152. Pediatr Hematol Oncol. 2006. PMID: 16651238 Clinical Trial.

9

Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo.

Kuwahara Y, Hosoi H, Osone S, Kita M, Iehara T, Kuroda H, Sugimoto T. Kuwahara Y, et al. Among authors: sugimoto t. Clin Cancer Res. 2004 Sep 1;10(17):5940-8. doi: 10.1158/1078-0432.CCR-04-0192. Clin Cancer Res. 2004. PMID: 15355927

10

A case of a ewing sarcoma family tumor in the urinary bladder after treatment for acute lymphoblastic leukemia.

Osone S, Hosoi H, Tanaka K, Tsuchiya K, Iehara T, Morimoto A, Hashida T, Yamashita M, Kawabata K, Nishijo K, Toguchida J, Hata J, Sugimoto T. Osone S, et al. Among authors: sugimoto t. J Pediatr Hematol Oncol. 2007 Dec;29(12):841-4. doi: 10.1097/MPH.0b013e318158155b. J Pediatr Hematol Oncol. 2007. PMID: 18090934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,512 results

Search Page